Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5705926 | 0.91 | — | — | |
| SCHEMBL15256843 | 0.86 | KIF11 (0.37) | — | |
| SCHEMBL15256816 | 0.86 | — | — | |
| SCHEMBL10762136 | 0.80 | TSHR (0.44) | TSHRLMNA | |
| SCHEMBL28926933 | 0.80 | — | — | |
| SCHEMBL191241 | 0.79 | — | — | |
| SCHEMBL3022307 | 0.79 | CA1 (0.35) | TSHR | |
| SCHEMBL28926934 | 0.76 | — | — | |
| SCHEMBL11374678 | 0.76 | THRB (0.44) | TSHRLMNA | |
| SCHEMBL20145107 | 0.76 | THRB (0.44) | TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613414-A | Non-azolanet Process for the preparation of tam | 上海皓元医药股份有限公司 | 2025-03-14 | — | — | CN | claimed |
| EP-4452838-A1 | PROCESS FOR REMOVING WATER FROM BIS(FLUOROSULFONYL)IMIDE SOLUTIONS | SPECIALTY OPERATIONS FRANCE (FR) | 2024-10-30 | — | — | EP | claimed |
| US-12059467-B2 | Low-toxicity and high-efficiency orthoester mixture pharmaceutical adjuvant, preparation method thereof, and topical sustained release drug delivery formulation including same | ANHUI UNIVERSITY (CN) | 2024-08-13 | — | — | US | claimed |
| CN-118434672-A | Method for removing water from bis (fluorosulfonyl) imide solution | 法国特种经营公司 | 2024-08-02 | — | — | CN | claimed |
| CN-117819494-A | Purification method of lithium bis (fluorosulfonyl) imide | 宜都兴发化工有限公司 | 2024-04-05 | — | — | CN | claimed |
| US-20240108728-A1 | IMPROVED LOW-TOXICITY AND HIGH-EFFICIENCY ORTHOESTER MIXTURE PHARMACEUTICAL ADJUVANT, PREPARATION METHOD THEREOF, AND TOPICAL SUSTAINED RELEASE DRUG DELIVERY FORMULATION INCLUDING SAME | ANHUI UNIVERSITY (CN) | 2024-04-04 | — | — | US | claimed |
| CN-112110862-B | Preparation method and application of 1,4,5, 6-tetrahydro-5-hydroxypyrimidine compound and hydrochloride thereof | 重庆华邦制药有限公司 | 2023-10-17 | — | — | CN | claimed |
| EP-4242173-A1 | PURIFICATION OF HYDROGEN BIS(FLUOROSULFONYL)IMIDE | SPECIALTY OPERATIONS FRANCE (FR) | 2023-09-13 | — | — | EP | claimed |
| WO-2023118115-A1 | PROCESS FOR REMOVING WATER FROM BIS(FLUOROSULFONYL)IMIDE SOLUTIONS | RHODIA OPERATIONS (FR) | 2023-06-29 | — | — | WO | claimed |
| US-7750095-B2 | System and method for reducing fouling in a reactor | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-07-06 | — | — | US | claimed |
| US-20100048837-A1 | System and method for reducing fouling in a reactor | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2010-02-25 | — | — | US | claimed |
| US-4025539-A | Process for preparing 2-substituted or unsubstituted geranyl acetic acids and esters thereof | KURARAY CO., LTD. (JA) | 1977-05-24 | — | — | US | claimed |
| CN-121154837-B | Crosslinked nano prodrug, nano self-assembled hydrogel precursor tablet prepared from crosslinked nano prodrug and application of nano self-assembled hydrogel precursor tablet | ANHUI UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-119613414-A | Non-azolanet Process for the preparation of tam | 上海皓元医药股份有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-119462662-A | Midazole Synthesis method of radix Armillaricis | 成都倍特药业股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| EP-4488317-A1 | METHOD FOR PRODUCING CURABLE RESIN COMPOSITION | Kaneka Corporation (JP) | 2025-01-08 | — | — | EP | disclosed |
| US-7750095-B2 | System and method for reducing fouling in a reactor | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-07-06 | — | — | US | disclosed |
| US-20100048837-A1 | System and method for reducing fouling in a reactor | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2010-02-25 | — | — | US | disclosed |
| US-4025539-A | Process for preparing 2-substituted or unsubstituted geranyl acetic acids and esters thereof | KURARAY CO., LTD. (JA) | 1977-05-24 | — | — | US | disclosed |
| US-3975381-A | Process for preparing γ-lactone derivatives | SAGAMI CHEMICAL RESEARCH CENTER (JA) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108728-A1 | IMPROVED LOW-TOXICITY AND HIGH-EFFICIENCY ORTHOESTER MIXTURE PHARMACEUTICAL ADJUVANT, PREPARATION METHOD THEREOF, AND TOPICAL SUSTAINED RELEASE DRUG DELIVERY FORMULATION INCLUDING SAME | TLR7, PON1, MYD88 | TSHR 3221/4885LMNA 4613/4885 |
| US-12059467-B2 | Low-toxicity and high-efficiency orthoester mixture pharmaceutical adjuvant, preparation method thereof, and topical sustained release drug delivery formulation including same | TLR7, PON1, MYD88 | TSHR 3173/4885LMNA 4595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.